Filing Details
- Accession Number:
- 0001104659-19-069103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-02 19:00:54
- Reporting Period:
- 2019-11-27
- Accepted Time:
- 2019-12-02 19:00:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1270073 | Intercept Pharmaceuticals Inc. | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1493811 | Christian Weyer | C/O Intercept Pharmaceuticals, Inc. 10 Hudson Yards, Floor 37 New York NY 10001 | Evp, Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-27 | 875 | $59.12 | 16,634 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-27 | 52 | $58.74 | 16,686 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-27 | 1,040 | $101.65 | 15,646 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-27 | 357 | $109.16 | 15,289 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase Common Stock | Disposition | 2019-11-27 | 875 | $0.00 | 875 | $59.12 |
| Common Stock | Option to Purchase Common Stock | Disposition | 2019-11-27 | 52 | $0.00 | 52 | $58.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,108 | 2027-11-27 | No | 4 | M | Direct | |
| 2,937 | 2028-02-05 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
- Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person.
- The award is subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial installment on the anniversary of the Vesting Start Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Start Date was November 27, 2017.
- The award is subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial installment on the anniversary of the Vesting Start Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Start Date was January 1, 2018.
Billionaire Hedge Funds
